Research location
Wuxi
Jiangsu, China
Advertisement
Research activity in Wuxi
Jiangsu, ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 128 trials and 142 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Wuxi
128 linked trials · page 1 of 3This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.NCT07649122 · 2026-08-31 · 1 site observation
RECRUITING
The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate CancerNCT07542379 · 2026-08-31 · 1 site observation
RECRUITING
Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.NCT07615101 · 2026-08-06 · 1 site observation
RECRUITING
Clinical Evaluation of SRT-017 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate CancerNCT07798778 · 2026-07-30 · 1 site observation
RECRUITING
A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSANCT07604116 · 2026-06-15 · 1 site observation
RECRUITING
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid TumorsNCT07459283 · 2026-04-20 · 1 site observation
RECRUITING
Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNCT07464587 · 2026-04-14 · 2 site observations
RECRUITING
Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary DiseaseNCT07068438 · 2025-09-01 · 1 site observation
RECRUITING
3D1015 Injection for Patients With mCRPCNCT07537010 · 2025-08-27 · 1 site observation
RECRUITING
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 1 site observation
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 1 site observation
RECRUITING
A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate CancerNCT06970119 · 2025-05-14 · 1 site observation
RECRUITING
TQC2731 Clinical Trial for the Treatment of Severe Asthma With InjectionNCT06829784 · 2025-03-21 · 1 site observation
RECRUITING
JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C MutationNCT06416410 · 2024-08-07 · 1 site observation
RECRUITING
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)NCT06345729 · 2024-05-24 · 1 site observation
RECRUITING
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy FailureNCT06300177 · 2024-03-28 · 2 site observations
RECRUITING
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)NCT06136624 · 2023-12-31 · 1 site observation
RECRUITING
Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate CancerNCT06139575 · 2023-12-22 · 1 site observation
RECRUITING
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)NCT06136650 · 2023-12-18 · 1 site observation
RECRUITING
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)NCT06170788 · 2023-12-15 · 1 site observation
RECRUITING
A Study of DB-1310 in Advanced/Metastatic Solid TumorsNCT05785741 · 2023-08-17 · 1 site observation
RECRUITING
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsNCT05150691 · 2022-01-31 · 1 site observation
RECRUITING
Left Ventricular Myocardial Work for Predicting Response to CRTNCT07319065 · 2026-01-01 · 2 site observations
NOT_YET_RECRUITING
A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation PowderNCT07252908 · 2025-12-22 · 1 site observation
COMPLETED
Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNCT07147946 · 2025-09-01 · 2 site observations
NOT_YET_RECRUITING
PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant TumorsNCT07023848 · 2025-07-01 · 1 site observation
ENROLLING_BY_INVITATION
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive MalignanciesNCT07023861 · 2025-07-01 · 1 site observation
ENROLLING_BY_INVITATION
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese SubjectsNCT06738979 · 2025-03-20 · 3 site observations
COMPLETED
A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT06707883 · 2024-12-31 · 2 site observations
ACTIVE_NOT_RECRUITING
A Phase II Study to Evaluate NH102 for DepressionNCT06842992 · 2024-12-04 · 1 site observation
COMPLETED
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).NCT06606509 · 2024-11-07 · 1 site observation
NOT_YET_RECRUITING
Evaluation of [68Ga]DOTA-IR-780-C-4 in PET Imaging Studies for PSMA-Positive Prostate Cancer PatientsNCT07162779 · 2024-10-29 · 1 site observation
ENROLLING_BY_INVITATION
Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive DisorderNCT07253207 · 2024-10-17 · 1 site observation
COMPLETED
A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT06527144 · 2024-09-14 · 2 site observations
COMPLETED
Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in PatientsNCT06389695 · 2024-06-04 · 1 site observation
COMPLETED
Henagliflozin's Impact on Prediabetes RemissionNCT06448130 · 2024-06-01 · 1 site observation
NOT_YET_RECRUITING
An Exploratory Study of Deep Cervical Lymphovenous Bypass (LVB) in Alzheimer's DiseaseNCT06448975 · 2024-05-31 · 1 site observation
UNKNOWN
Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate CancerNCT05707468 · 2024-05-01 · 1 site observation
NOT_YET_RECRUITING
The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer PatientsNCT06723665 · 2024-01-25 · 1 site observation
ENROLLING_BY_INVITATION
A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe DepressionNCT06259526 · 2023-12-26 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary FibrosisNCT06025578 · 2023-10-25 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung CancerNCT06029127 · 2023-10-23 · 1 site observation
COMPLETED
Evaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate CancerNCT06809426 · 2023-08-21 · 1 site observation
COMPLETED
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 DiabetesNCT05872620 · 2023-06-05 · 1 site observation
COMPLETED
A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 SchizophreniaNCT05919823 · 2023-05-29 · 1 site observation
COMPLETED
The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19NCT05855395 · 2023-05-26 · 1 site observation
UNKNOWN
177Lu-labeled NY108 SPECT Imaging in PatientsNCT05815394 · 2023-03-03 · 1 site observation
UNKNOWN
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 DiabetesNCT05691712 · 2023-02-05 · 1 site observation
COMPLETED
Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung CancerNCT05669586 · 2023-02-01 · 1 site observation
UNKNOWN
Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor EfficacyNCT05828238 · 2023-01-01 · 1 site observation
UNKNOWN
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.